<DOC>
	<DOCNO>NCT00620256</DOCNO>
	<brief_summary>The purpose study compare safety intraocular pressure-lowering efficacy AL-37807 ophthalmic suspension vs. Timolol gel form solution vs. AL-37807 vehicle , dose concomitantly Xalatan , patient open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Adjunctive Study AL-37807 Ophthalmic Suspension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Openangle glaucoma Ocular hypertension Must Xalatan least 3 month VA bad 0.60 Other protocoldefined inclusion criterion may apply Age related Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Hypertension</keyword>
</DOC>